2023
New strategic alliances in Parkinson and aging
2022
Pre-IND meeting with the FDA
2021
Beginning of the preclinical regulatory phase
2020
Method of validation of TET-101
2019
Analysis of biological processes modulated by E2F4DN
2018
Validation of the Leading Compound
2017
Validation of the Leading Compound
2016
Identification of the Leading Compound
2015
Validation of the therapeutical target E2F4DN
2014
Beginning of the proof of concept
2013
Identification of the therapeutical target E2F4
2012
Tetraneuron was founded
At Tetraneuron, we are honoured to have our scientific roots in the institute where, back in the early 1900s, Santiago Ramón y Cajal developed pioneering research about the fine structure of the nervous system of the brain and spinal cord, allowing him to earn the prestigious Nobel prize in 1906. With more than 100 publications in both Spanish and French and prolific research activities, Ramón y Cajal’s work provided the foundational understanding of neural structure and function, which is critical for comprehending neurological disorders and neurodegeneration. His contribution to the study of neuroscience and neurodegeneration includes the establishment of the “Neuron Doctrine”, which states that neurons are discrete cells and demonstrates that they communicate through junctions (synapses). In the images we share here, Cajal’s offers detailed and artful representations or the brain, feed the mounting evidence about this organ being as vast and mysterious as the universe.
Con sede en Madrid y Valencia, Tetraneuron nace como spin-off del Instituto Cajal, perteneciente al Consejo Superior de Investigaciones Científicas (CSIC)